MLN8237 (Alisertib): Applied Protocols for Cancer Biology Re
2026-05-29
MLN8237 (Alisertib) empowers cancer researchers to dissect Aurora A kinase function, enabling precision workflows for apoptosis induction and tumor inhibition. This guide details validated protocols, practical troubleshooting, and the latest insights from epigenetic and immune studies to maximize experimental impact.
Bedaquiline: Diarylquinoline Antibiotic for MDR-TB & Cancer
2026-05-28
Bedaquiline, a diarylquinoline antibiotic from APExBIO, uniquely targets Mycobacterium tuberculosis F1FO-ATP synthase and disrupts cancer stem cell metabolism. Discover practical workflows, troubleshooting strategies, and protocol innovations that make Bedaquiline a pivotal tool for tackling multidrug-resistant tuberculosis and advancing cancer metabolism studies.
Dual-Action Inhibition Modulates p38α MAPK Dephosphorylation
2026-05-28
This study uncovers how certain kinase inhibitors, by stabilizing specific activation loop conformations of p38α MAP kinase, not only block kinase activity but also accelerate dephosphorylation by phosphatases. These dual-action inhibitors offer a new avenue for improving specificity and potency in therapeutic targeting of MAPK signaling.
Thiothixene: Typical Antipsychotic Agent Enhancing Efferocyt
2026-05-27
Thiothixene uniquely bridges neuropsychiatry and immunology, serving as both a typical antipsychotic agent and a potent enhancer of macrophage efferocytosis. This guide translates bench findings into actionable protocols, troubleshooting, and cross-domain insights for researchers leveraging APExBIO’s high-quality Thiothixene in advanced experimental workflows.
Deferasirox Fe3+ Chelate: Translational Insights for Iron Ov
2026-05-27
Explore the scientific rationale and protocol considerations for Deferasirox Fe3+ chelate in advanced iron overload research. This article goes beyond pharmacokinetics, providing practical assay insights and highlighting the unique translational value of this APExBIO reagent.
Inducing Embryonic Dormancy In Vitro via mTOR Inhibition Pro
2026-05-26
The reference study introduces robust, in vitro protocols for inducing a reversible diapause-like dormant state in mammalian embryos and pluripotent stem cells using mTOR inhibition. This advance simplifies and scales dormancy research, enabling new investigations into developmental timing and cell fate control.
Cefazedone (Refosporen): Applied Workflows for Antibacterial
2026-05-26
Cefazedone (Refosporen) stands out as a β-lactamase-resistant, first-generation cephalosporin optimized for both in vitro and in vivo antibacterial workflows. This guide delivers actionable, evidence-backed protocols and troubleshooting strategies that maximize reliability and translational impact in research on Gram-positive and Gram-negative infections.
Cy5.5 NHS Ester (Non-Sulfonated): Advancing Tumor Imaging Wo
2026-05-26
Cy5.5 NHS ester (non-sulfonated) delivers high-sensitivity, near-infrared labeling for robust protein and nucleic acid tracking in advanced optical imaging. Its optimized workflow enables precise in vivo tumor visualization and microbiome-targeted research, supported by recent translational breakthroughs.
Captopril as an ACE Inhibitor: Experimental Workflows & Insi
2026-05-25
Unleash the full potential of Captopril in hypertension and cancer research with data-driven workflows and troubleshooting rooted in recent bradykinin pathway advances. This guide translates mechanistic evidence into actionable steps, enabling reproducible, high-impact experiments with APExBIO's high-purity Captopril.
Azithromycin and Roxithromycin as Novel Senolytics in Fibrob
2026-05-24
Ozsvari et al. (2018) identified azithromycin and roxithromycin as a distinctive new class of senolytic drugs, capable of selectively eliminating senescent human fibroblasts. Their work demonstrates a streamlined drug-repurposing assay and highlights the importance of robust senescence detection methods for translational aging research.
Danazol in Endocrine Benchwork: Applied Models and Protocol
2026-05-23
Leverage Danazol (Danocrine) to build robust models of steroidogenesis inhibition and hypothalamic–pituitary–gonadal (HPG) axis modulation. This guide details stepwise workflows, advanced troubleshooting, and experimental insights that make APExBIO’s Danazol a gold standard for reproducible endocrine and prostate cancer research.
Toxicology and Mechanisms of Decitabine in Murine Models
2026-05-22
This study provides a systematic toxicological assessment of Decitabine (5-Aza-2'-deoxycytidine) in mice, establishing dose-limiting toxicities and reversible tissue effects. These findings inform safe experimental design and translational research in cancer epigenetics, particularly for hematopoietic malignancies.
CasKAS Enables Rapid Genome-Wide CRISPR Off-Target Mapping
2026-05-22
The CasKAS method introduces a fast, cost-effective assay for direct profiling of dCas9 and Cas9 specificity genome-wide by mapping single-stranded DNA generated upon CRISPR binding. This approach enables more accessible detection of off-target activity in both in vitro and in vivo contexts, addressing major limitations of previous techniques and supporting safer genome engineering.
Gut Dysbiosis Drives Prostate Cancer Progression and Docetax
2026-05-21
Zhong et al. provide compelling evidence that gut microbiota imbalance, particularly Proteobacteria enrichment following antibiotic exposure, promotes prostate cancer growth and resistance to Docetaxel via activation of the NF-κB-IL6-STAT3 axis. These findings highlight the gut-tumor axis as a key factor in chemoresistance, suggesting microbiome modulation as a potential adjunct in cancer therapy.
Applied Workflows with 12-O-tetradecanoyl phorbol-13-acetate
2026-05-21
12-O-tetradecanoyl phorbol-13-acetate (TPA) empowers high-fidelity ERK/MAPK pathway activation, offering unmatched consistency in signal transduction and skin cancer models. This guide delivers hands-on protocol optimization, practical troubleshooting, and strategic insights for advanced research leveraging APExBIO’s TPA.
459 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page